Pre-eclampsia has an adverse impact on maternal and fetal health.

[1]  D. Zawieja,et al.  Suppression of aldosterone and progesterone in preeclampsia , 2015, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[2]  D. Zawieja,et al.  Hyperglycemia impairs cytotrophoblast function via stress signaling. , 2014, American journal of obstetrics and gynecology.

[3]  Lena Perger,et al.  Intrauterine growth restriction and prematurity influence regulatory T cell development in newborns. , 2014, Journal of pediatric surgery.

[4]  G. Saade,et al.  Effects of Pravastatin on Angiogenic and Placental Hypoxic Imbalance in a Mouse Model of Preeclampsia , 2014, Reproductive Sciences.

[5]  F. Frey,et al.  Vascular Endothelial Growth Factor-A and Aldosterone: Relevance to Normal Pregnancy and Preeclampsia , 2013, Hypertension.

[6]  C. Delles,et al.  Aldosterone, vascular endothelial growth factor, and preeclampsia: a mystery solved? , 2013, Hypertension.

[7]  A. Hakim,et al.  Preeclampsia Is a Biomarker for Vascular Disease in Both Mother and Child: The Need for a Medical Alert System , 2013, International journal of pediatrics.

[8]  M. Çetinkaya,et al.  Maternal preeclampsia is associated with increased risk of necrotizing enterocolitis in preterm infants. , 2012, Early human development.

[9]  R. Tal.  The Role of Hypoxia and Hypoxia-Inducible Factor-1Alpha in Preeclampsia Pathogenesis , 2012, Biology of reproduction.

[10]  J. Aarnoudse,et al.  Long‐term cerebral imaging after pre‐eclampsia , 2012, BJOG : an international journal of obstetrics and gynaecology.

[11]  C. D. de Groot,et al.  Preeclampsia and cardiovascular risk. , 2012, Minerva ginecologica.

[12]  D. Zawieja,et al.  Pathogenesis of pre-eclampsia: marinobufagenin and angiogenic imbalance as biomarkers of the syndrome. , 2012, Translational research : the journal of laboratory and clinical medicine.

[13]  M. Çetinkaya,et al.  Increased incidence of bronchopulmonary dysplasia in preterm infants exposed to preeclampsia , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[14]  D. Steinberg,et al.  Cell Free Expression of hif1α and p21 in Maternal Peripheral Blood as a Marker for Preeclampsia and Fetal Growth Restriction , 2012, PloS one.

[15]  P. Leeson,et al.  Pre-eclampsia and offspring cardiovascular health: mechanistic insights from experimental studies , 2012, Clinical science.

[16]  H. Maul,et al.  Gestational diabetes and preeclampsia--similar risk factor profiles? , 2012, Early human development.

[17]  J. Eriksson,et al.  Hypertensive disorders in pregnancy and risk of severe mental disorders in the offspring in adulthood: the Helsinki Birth Cohort Study. , 2012, Journal of psychiatric research.

[18]  L. Doyle,et al.  Maternal preeclampsia and risk of bronchopulmonary dysplasia in preterm infants , 2012, Pediatric Research.

[19]  S. Hansson,et al.  Review: Biochemical markers to predict preeclampsia. , 2012, Placenta.

[20]  D. Schust,et al.  Preeclampsia: multiple approaches for a multifactorial disease , 2012, Disease Models & Mechanisms.

[21]  C. Parker,et al.  Association between stillbirth and risk factors known at pregnancy confirmation. , 2011, JAMA.

[22]  D. Lawlor,et al.  Cardiovascular biomarkers and vascular function during childhood in the offspring of mothers with hypertensive disorders of pregnancy: findings from the Avon Longitudinal Study of Parents and Children , 2011, European heart journal.

[23]  D. Green,et al.  HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells , 2011, The Journal of experimental medicine.

[24]  R. Troisi,et al.  Endothelial Function and Circulating Biomarkers Are Disturbed in Women and Children After Preeclampsia , 2011, Hypertension.

[25]  R. Levine,et al.  Preeclampsia, a Disease of the Maternal Endothelium: The Role of Antiangiogenic Factors and Implications for Later Cardiovascular Disease , 2011, Circulation.

[26]  J. Olsen,et al.  Diseases in children born to mothers with preeclampsia: a population-based sibling cohort study. , 2011, American journal of obstetrics and gynecology.

[27]  C. Weydert,et al.  Adenoviral Delivery of VEGF121 Early in Pregnancy Prevents Spontaneous Development of Preeclampsia in BPH/5 Mice , 2011, Hypertension.

[28]  K. Räikkönen,et al.  Depressive symptoms in adulthood and intrauterine exposure to pre‐eclampsia: the Helsinki Birth Cohort Study , 2010, BJOG : an international journal of obstetrics and gynaecology.

[29]  C. Sartori,et al.  Pulmonary and Systemic Vascular Dysfunction in Young Offspring of Mothers With Preeclampsia , 2010, Circulation.

[30]  M. Çetinkaya,et al.  Neonatal outcomes of premature infants born to preeclamptic mothers , 2010, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[31]  J. Folkman,et al.  Maternal preeclampsia predicts the development of bronchopulmonary dysplasia. , 2010, The Journal of pediatrics.

[32]  V. Whiteman,et al.  Pre-eclampsia in the first pregnancy and subsequent risk of stillbirth in black and white gravidas. , 2010, European journal of obstetrics, gynecology, and reproductive biology.

[33]  C. Ananth,et al.  Impact of Pregnancy-induced Hypertension on Stillbirth and Neonatal Mortality , 2010, Epidemiology.

[34]  John C Chappell,et al.  Local guidance of emerging vessel sprouts requires soluble Flt-1. , 2009, Developmental cell.

[35]  J. Olsen,et al.  Health of children born to mothers who had preeclampsia: a population-based cohort study. , 2009, American journal of obstetrics and gynecology.

[36]  B. Sibai,et al.  Hypertensive Pregnancy Disorders and Subsequent Cardiovascular Morbidity and Type 2 Diabetes Mellitus in the Mother , 2009, Hypertension.

[37]  J. Kere,et al.  Blood group AB and factor V Leiden as risk factors for pre-eclampsia: a population-based nested case-control study. , 2009, Thrombosis research.

[38]  J. Shapiro,et al.  Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic Targets , 2009, Pharmacological Reviews.

[39]  B. Tharakan,et al.  Vascular Leak in a Rat Model of Preeclampsia , 2009, American Journal of Nephrology.

[40]  S. Yusuf,et al.  Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. , 2008, American heart journal.

[41]  Tiejuan Mi,et al.  Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice , 2008, Nature Medicine.

[42]  B. Duncan,et al.  Gestational diabetes and pre-eclampsia: common antecedents? , 2008, Arquivos brasileiros de endocrinologia e metabologia.

[43]  Peter D Gluckman,et al.  Effect of in utero and early-life conditions on adult health and disease. , 2008, The New England journal of medicine.

[44]  S. Glaser,et al.  Examination of the Cellular Mechanisms by Which Marinobufagenin Inhibits Cytotrophoblast Function* , 2008, Journal of Biological Chemistry.

[45]  A. Dubois,et al.  Preeclampsia is Associated with Lower Percentages of Regulatory T Cells in Maternal Blood , 2008, Hypertension in pregnancy.

[46]  J. Granger,et al.  Hypertension Produced by Reduced Uterine Perfusion in Pregnant Rats Is Associated With Increased Soluble Fms-Like Tyrosine Kinase-1 Expression , 2007, Hypertension.

[47]  B. Quinn.  Pharmacological Treatment of Heart Failure , 2007, Critical care nursing quarterly.

[48]  G. Scheiner-Bobis,et al.  Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. , 2007, American journal of physiology. Cell physiology.

[49]  Y. Sasaki,et al.  The role of the immune system in preeclampsia. , 2007, Molecular aspects of medicine.

[50]  H. Masuyama,et al.  Expression and potential role of peroxisome proliferator-activated receptor gamma in the placenta of diabetic pregnancy. , 2007, Placenta.

[51]  Barbara Schiessl,et al.  Inflammatory response in preeclampsia. , 2007, Molecular aspects of medicine.

[52]  E. Lakatta,et al.  Endogenous Na/K-ATPase inhibitors in patients with preeclampsia. , 2006, Cellular and molecular biology.

[53]  R. Weiss,et al.  Severe Feto-Placental Abnormalities Precede the Onset of Hypertension and Proteinuria in a Mouse Model of Preeclampsia1 , 2006, Biology of reproduction.

[54]  I. Sargent,et al.  NK cells and human pregnancy--an inflammatory view. , 2006, Trends in immunology.

[55]  C. Morris,et al.  Marinobufagenin impairs first trimester cytotrophoblast differentiation. , 2006, Placenta.

[56]  Eugenia K. Pallotto,et al.  Perinatal Outcome and Later Implications of Intrauterine Growth Restriction , 2006, Clinical obstetrics and gynecology.

[57]  T. Libermann,et al.  Soluble endoglin contributes to the pathogenesis of preeclampsia , 2006, Nature Medicine.

[58]  L. Myatt.  Placental adaptive responses and fetal programming , 2006, The Journal of physiology.

[59]  P. Bischof,et al.  Involvement of MAPK pathway in TNF-α-induced MMP-9 expression in human trophoblastic cells , 2006 .

[60]  J. Deloia,et al.  Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines. , 2006, Clinical immunology.

[61]  H. Drexler,et al.  The clinical significance of endothelial dysfunction , 2005, Current opinion in cardiology.

[62]  G. Scheiner-Bobis,et al.  Endogenous cardiac glycosides: hormones using the sodium pump as signal transducer. , 2005, Seminars in nephrology.

[63]  J. Puschett,et al.  Involvement of Marinobufagenin in a Rat Model of Human Preeclampsia , 2005, American Journal of Nephrology.

[64]  A. Fukamizu,et al.  Differential roles of renin and angiotensinogen in the feto-maternal interface in the development of complications of pregnancy. , 2005, Molecular endocrinology.

[65]  Nick Evans,et al.  Aortic wall thickness in newborns with intrauterine growth restriction , 2005, The Lancet.

[66]  E. Podjarny,et al.  Animal models of preeclampsia. , 2004, Seminars in nephrology.

[67]  J. Thorp,et al.  Intrauterine growth restriction increases morbidity and mortality among premature neonates. , 2004, American journal of obstetrics and gynecology.

[68]  U. Hanson,et al.  Gestational diabetes and preeclampsia. , 2004, European journal of obstetrics, gynecology, and reproductive biology.

[69]  S. Chakrabarti,et al.  p38 MAP kinase regulates rapid matrix metalloproteinase-9 release from eosinophils. , 2004, Biochemical and biophysical research communications.

[70]  K. Lim,et al.  Circulating angiogenic factors and the risk of preeclampsia. , 2004, The New England journal of medicine.

[71]  A. Fukamizu,et al.  An essential role for angiotensin II Type 1a receptor in pregnancy‐associated hypertension with intrauterine growth retardation , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[72]  E. Sheiner,et al.  Maternal Hypertensive Disorders Are an Independent Risk Factor for the Development of Necrotizing Enterocolitis in Very Low Birth Weight Infants , 2003, Fetal Diagnosis and Therapy.

[73]  N. Sattar,et al.  Classic and Novel Risk Factor Parameters in Women With a History of Preeclampsia , 2003, Hypertension.

[74]  T. Libermann,et al.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia , 2003 .

[75]  J. Kingdom,et al.  Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation. , 2003, Placenta.

[76]  K. Ward,et al.  A Molecular Variant of Angiotensinogen Is Associated With Idiopathic Intrauterine Growth Restriction , 2003, Obstetrics and gynecology.

[77]  D. Luthy,et al.  Influence of pre-eclampsia on fetal growth , 2003, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[78]  G. Dekker.  The partner's role in the etiology of preeclampsia. , 2002, Journal of reproductive immunology.

[79]  W. Schoner.  Endogenous cardiac glycosides, a new class of steroid hormones. , 2002, European journal of biochemistry.

[80]  A. Vambergue,et al.  Pregnancy induced hypertension in women with gestational carbohydrate intolerance: the diagest study. , 2002, European journal of obstetrics, gynecology, and reproductive biology.

[81]  S. Mizutani,et al.  Possible activation of the renin-angiotensin system in the feto-placental unit in preeclampsia. , 2002, The Journal of clinical endocrinology and metabolism.

[82]  N. Ferrara,et al.  Characterization of Endocrine Gland-derived Vascular Endothelial Growth Factor Signaling in Adrenal Cortex Capillary Endothelial Cells* , 2002, The Journal of Biological Chemistry.

[83]  R. Weiss,et al.  Discovery of a Spontaneous Genetic Mouse Model of Preeclampsia , 2002, Hypertension.

[84]  G. Wallukat,et al.  The upregulation of angiotensin II receptor AT1 in human preeclamptic placenta , 2001, Molecular and Cellular Endocrinology.

[85]  S. Fisher,et al.  Implantation and the survival of early pregnancy. , 2001, The New England journal of medicine.

[86]  H. Lother,et al.  Increased AT1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness , 2001, Nature Medicine.

[87]  J. Kooner,et al.  Association of maternal endothelial dysfunction with preeclampsia. , 2001, JAMA.

[88]  M. Varner,et al.  Paternal and maternal components of the predisposition to preeclampsia. , 2001, The New England journal of medicine.

[89]  A. Lucas,et al.  Impact of Low Birth Weight and Cardiovascular Risk Factors on Endothelial Function in Early Adult Life , 2001, Circulation.

[90]  E. Lakatta,et al.  Marinobufagenin, an Endogenous α-1 Sodium Pump Ligand, in Hypertensive Dahl Salt-Sensitive Rats , 2001 .

[91]  Jm Roberts,et al.  Pathogenesis and genetics of pre-eclampsia , 2001, The Lancet.

[92]  L. Vatten,et al.  Preeclampsia and Fetal Growth , 2000, Obstetrics and gynecology.

[93]  D. Ganten,et al.  Rats transgenic for human renin and human angiotensinogen as a model for gestational hypertension. , 2000, Journal of the American Society of Nephrology : JASN.

[94]  R. Ansari,et al.  Definitive molecular evidence of renin-angiotensin system in human uterine decidual cells. , 2000, Hypertension.

[95]  K. Conrad,et al.  Expression, Ontogeny, and Regulation of Hypoxia-Inducible Transcription Factors in the Human Placenta1 , 2000, Biology of reproduction.

[96]  S. Hayakawa,et al.  Murine fetal resorption and experimental pre-eclampsia are induced by both excessive Th1 and Th2 activation. , 2000, Journal of reproductive immunology.

[97]  A. Nielsen,et al.  Current topic: the uteroplacental renin-angiotensin system. , 2000, Placenta.

[98]  W. Grzeszczak,et al.  Angiotensin II type 1 receptor gene A1166C polymorphism is associated with the increased risk of pregnancy-induced hypertension. , 2000, Medical science monitor : international medical journal of experimental and clinical research.

[99]  P. Donahoe,et al.  Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[100]  C. Ockleford,et al.  Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation. , 2000, Placenta.

[101]  M. Gassmann,et al.  Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFβ3 , 2000 .

[102]  C. Hubel,et al.  Oxidative Stress in the Pathogenesis of Preeclampsia (44447) , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[103]  O. Fedorova,et al.  Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. , 1999, Journal of hypertension.

[104]  G. Robinson,et al.  The localization and expression of the renin-angiotensin system in the human placenta throughout pregnancy. , 1999, Placenta.

[105]  G. Wallukat,et al.  Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. , 1999, The Journal of clinical investigation.

[106]  R. Hayman,et al.  Preeclampsia: The Endothelium, Circulating Factor(s) and Vascular Endothelial Growth Factor , 1999, The Journal of the Society for Gynecologic Investigation: JSGI.

[107]  O. Fedorova,et al.  Effects of two putative endogenous digitalis‐like factors, marinobufagenin and ouabain, on the Na+,K+‐pump in human mesenteric arteries , 1998, Journal of hypertension.

[108]  C. Craven,et al.  Human spiral artery renin-angiotensin system. , 1998, Hypertension.

[109]  D. Rouse,et al.  Prevention of premature birth. , 1998, The New England journal of medicine.

[110]  N. Vaziri,et al.  Simultaneous measurement of marinobufagenin, ouabain, and hypertension-associated protein in various disease states. , 1998, Clinical and experimental hypertension.

[111]  O. Fedorova,et al.  Endogenous marinobufagenin-like factor in acute plasma volume expansion. , 1998, Clinical and experimental hypertension.

[112]  M. Montgomery,et al.  The role of AT1 angiotensin receptor activation in the pathogenesis of preeclampsia. , 1998, American journal of obstetrics and gynecology.

[113]  R. T. Lie,et al.  Fetal and maternal contributions to risk of pre-eclampsia: population based study , 1998, BMJ.

[114]  K. Lim,et al.  Circulating Factors as Markers and Mediators of Endothelial Cell Dysfunction in Preeclampsia , 1998, Seminars in reproductive endocrinology.

[115]  H. Chapman,et al.  Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. , 1997, Current opinion in cell biology.

[116]  J. Lalouel,et al.  Angiotensinogen T235 expression is elevated in decidual spiral arteries. , 1997, The Journal of clinical investigation.

[117]  Y. Wei,et al.  Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin. , 1997, The Journal of clinical investigation.

[118]  E. Dejana,et al.  Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? , 1997, The Journal of clinical investigation.

[119]  C. Damsky,et al.  Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? , 1997, The Journal of clinical investigation.

[120]  A. Fukamizu,et al.  Hypertension Induced in Pregnant Mice by Placental Renin and Maternal Angiotensinogen , 1996, Science.

[121]  O. Fedorova,et al.  Plasma marinobufagenin-like and ouabain-like immunoreactivity during saline volume expansion in anesthetized dogs. , 1996, Cardiovascular research.

[122]  A. Campana,et al.  Importance of matrix metalloproteinases in human trophoblast invasion. , 1995, Early pregnancy : biology and medicine : the official journal of the Society for the Investigation of Early Pregnancy.

[123]  J. Winer,et al.  Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. , 1994, The Journal of biological chemistry.

[124]  M. Pamnani,et al.  Chronic Blood Pressure Effects of Bufalin, a Sodium‐Potassium ATPase Inhibitor, in Rats , 1994, Hypertension.

[125]  S. Sidney,et al.  Fetal growth retardation in infants of multiparous and nulliparous women with preeclampsia. , 1993, American journal of obstetrics and gynecology.

[126]  C. Damsky,et al.  Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. , 1993, The Journal of clinical investigation.

[127]  G. Viglietto,et al.  Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[128]  M. Blaustein,et al.  Effects of an Endogenous Ouabainlike Compound on Heart and Aorta , 1991, Hypertension.

[129]  M. Andrew,et al.  Neonatal thrombocytopenia in the hypertensive disorders of pregnancy , 1990, Obstetrics and gynecology.

[130]  T. Musci,et al.  Preeclampsia: an endothelial cell disorder. , 1989, American journal of obstetrics and gynecology.

[131]  G. Zhang,et al.  Adhesive and degradative properties of human placental cytotrophoblast cells in vitro , 1989, The Journal of cell biology.

[132]  W. Hsueh,et al.  Increased fetoplacental active renin production in pregnancy-induced hypertension. , 1987, American journal of obstetrics and gynecology.

[133]  M. Blaustein,et al.  A circulating inhibitor of (Na+ + K+) ATPase associated with essential hypertension , 1982, Nature.

[134]  M. Blaustein.  Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. , 1977, The American journal of physiology.

[135]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1941 .

[136]  E. Staun-ram,et al.  Reproductive Biology and Endocrinology Open Access Expression and Importance of Matrix Metalloproteinase 2 and 9 (mmp-2 and -9) in Human Trophoblast Invasion , 2004 .

[137]  S. Chauhan,et al.  Differential activity of cathepsin L in human placenta at two different stages of gestation. , 2002, Placenta.

[138]  J. Lalouel,et al.  Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua. , 1999, American journal of obstetrics and gynecology.

[139]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.

[140]  R. Kramer,et al.  Degradation of extracellular matrix by the trophoblastic cells of first‐trimester human placentas , 1985, Journal of cellular biochemistry.

[141]  H. D. Wardener.  The concept of the natriuretic hormone and its relation to hypertension. , 1985 .

[142]  R. Pijnenborg,et al.  Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy. , 1980, Placenta.